78 related articles for article (PubMed ID: 24762501)
1. A novel role of the tumor size in pancreatic cancer as an ancillary factor for predicting resectability.
Chiang KC; Lee CH; Yeh CN; Ueng SH; Hsu JT; Yeh TS; Jan YY; Hwang TL; Chen MF
J Cancer Res Ther; 2014; 10(1):142-6. PubMed ID: 24762501
[TBL] [Abstract][Full Text] [Related]
2. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH
J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409
[TBL] [Abstract][Full Text] [Related]
3. Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma.
Maithel SK; Maloney S; Winston C; Gönen M; D'Angelica MI; Dematteo RP; Jarnagin WR; Brennan MF; Allen PJ
Ann Surg Oncol; 2008 Dec; 15(12):3512-20. PubMed ID: 18781364
[TBL] [Abstract][Full Text] [Related]
4. CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients.
Santucci N; Facy O; Ortega-Deballon P; Lequeu JB; Rat P; Rat P
Pancreatology; 2018 Sep; 18(6):666-670. PubMed ID: 30153902
[TBL] [Abstract][Full Text] [Related]
5. Role of endoscopic ultrasound and magnetic resonance imaging in the preoperative staging of pancreatic adenocarcinoma.
Ahmad NA; Lewis JD; Siegelman ES; Rosato EF; Ginsberg GG; Kochman ML
Am J Gastroenterol; 2000 Aug; 95(8):1926-31. PubMed ID: 10950037
[TBL] [Abstract][Full Text] [Related]
6. High serum CA 19-9 but not tumor size should select patients for staging laparoscopy in radiological resectable pancreas head and peri-ampullary cancer.
Alexakis N; Gomatos IP; Sbarounis S; Toutouzas K; Katsaragakis S; Zografos G; Konstandoulakis MM
Eur J Surg Oncol; 2015 Feb; 41(2):265-9. PubMed ID: 25266999
[TBL] [Abstract][Full Text] [Related]
7. Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer.
Chiang KC; Yeh CN; Ueng SH; Hsu JT; Yeh TS; Jan YY; Hwang TL; Chen MF
World J Surg Oncol; 2012 May; 10():77. PubMed ID: 22559838
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma.
Fujioka S; Misawa T; Okamoto T; Gocho T; Futagawa Y; Ishida Y; Yanaga K
J Hepatobiliary Pancreat Surg; 2007; 14(6):539-44. PubMed ID: 18040617
[TBL] [Abstract][Full Text] [Related]
9. CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy.
Hartwig W; Strobel O; Hinz U; Fritz S; Hackert T; Roth C; Büchler MW; Werner J
Ann Surg Oncol; 2013 Jul; 20(7):2188-96. PubMed ID: 23247983
[TBL] [Abstract][Full Text] [Related]
10. Value of preoperative serum CA 19-9 levels in predicting resectability for pancreatic cancer.
Kiliç M; Göçmen E; Tez M; Ertan T; Keskek M; Koç M
Can J Surg; 2006 Aug; 49(4):241-4. PubMed ID: 16948881
[TBL] [Abstract][Full Text] [Related]
11. Preoperative high level of D-dimers predicts unresectability of pancreatic head cancer.
Durczynski A; Kumor A; Hogendorf P; Szymanski D; Grzelak P; Strzelczyk J
World J Gastroenterol; 2014 Sep; 20(36):13167-71. PubMed ID: 25278712
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma.
Zhang S; Wang YM; Sun CD; Lu Y; Wu LQ
World J Gastroenterol; 2008 Jun; 14(23):3750-3. PubMed ID: 18595144
[TBL] [Abstract][Full Text] [Related]
13. [MRI in the evaluation of peripancreatic vessel invasion and resectability of pancreatic carcinoma].
Wang DQ; Zeng MS; Jin DY; Lou WH; Ji Y; Rao SX; Shi X; Chen CZ; Li RC
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):846-9. PubMed ID: 18396644
[TBL] [Abstract][Full Text] [Related]
14. CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma.
Liu P; Zhu Y; Liu L
Int J Clin Exp Pathol; 2015; 8(11):15112-7. PubMed ID: 26823852
[TBL] [Abstract][Full Text] [Related]
15. Multimodality staging optimizes resectability in patients with pancreatic and ampullary cancer.
Awad SS; Colletti L; Mulholland M; Knol J; Rothman ED; Scheiman J; Eckhauser FE
Am Surg; 1997 Jul; 63(7):634-8. PubMed ID: 9202539
[TBL] [Abstract][Full Text] [Related]
16. Tumour cryoablation combined with palliative bypass surgery in the treatment of unresectable pancreatic cancer: a retrospective study of 142 patients.
Li J; Chen X; Yang H; Wang X; Yuan D; Zeng Y; Wen T; Yan L; Li B
Postgrad Med J; 2011 Feb; 87(1024):89-95. PubMed ID: 21131612
[TBL] [Abstract][Full Text] [Related]
17. Morphometrical differences between resectable and non-resectable pancreatic cancer: a fractal analysis.
Vasilescu C; Giza DE; Petrisor P; Dobrescu R; Popescu I; Herlea V
Hepatogastroenterology; 2012; 59(113):284-8. PubMed ID: 22260836
[TBL] [Abstract][Full Text] [Related]
18. CA19-9 as a predictor of resectability in patients with borderline resectable pancreatic cancer.
He Z; Lu H; Du X; Hu W; Zhaoda BT
Hepatogastroenterology; 2013 Jun; 60(124):900-3. PubMed ID: 23321027
[TBL] [Abstract][Full Text] [Related]
19. Staging of pancreatic head adenocarcinoma with spiral CT and endoscopic ultrasonography: an indirect evaluation of the usefulness of laparoscopy.
Maire F; Sauvanet A; Trivin F; Hammel P; O'Toole D; Palazzo L; Vilgrain V; Belghiti J; Ruszniewski P; Levy P
Pancreatology; 2004; 4(5):436-40. PubMed ID: 15249711
[TBL] [Abstract][Full Text] [Related]
20. Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era?
Mayo SC; Austin DF; Sheppard BC; Mori M; Shipley DK; Billingsley KG
J Am Coll Surg; 2009 Jan; 208(1):87-95. PubMed ID: 19228509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
